These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9113200)

  • 21. In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone.
    Negrette B; Bonilla E; Valero N; Giraldoth D; Medina-Leendertz S; Añez F
    Invest Clin; 2001 Dec; 42(4):235-40. PubMed ID: 11787268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice.
    Schoneboom BA; Lee JS; Grieder FB
    J Interferon Cytokine Res; 2000 Feb; 20(2):205-15. PubMed ID: 10714557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apropos "neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in non-human primates".
    Arya SC; Agarwal N
    Vaccine; 2008 Aug; 26(35):4413. PubMed ID: 18602962
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus.
    Gupta P; Sharma A; Han J; Yang A; Bhomia M; Knollmann-Ritschel B; Puri RK; Maheshwari RK
    BMC Infect Dis; 2017 Apr; 17(1):309. PubMed ID: 28446152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placental and fetal alterations due to Venezuelan equine encephalitis virus in rats.
    García-Tamayo J; Esparza J; Martínez AJ
    Infect Immun; 1981 May; 32(2):813-21. PubMed ID: 7251148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
    Grieder FB; Vogel SN
    Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse.
    Charles PC; Walters E; Margolis F; Johnston RE
    Virology; 1995 Apr; 208(2):662-71. PubMed ID: 7747437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The course of airborne infection in rabbits infected with the Venezuelan encephalomyelitis virus].
    Sergeev AN; Ryzhikov AB; Bulychev LE; Stepkina EO; Tkacheva NV
    Vopr Virusol; 1991; 36(6):492-5. PubMed ID: 1785185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus].
    Sviatchenko VA; Agapov EV; Urmanov IKh; Serpinskiĭ OI; Frolov IV; Kolykhalov AA; Ryzhikov AB; Netesov SV
    Vopr Virusol; 1993; 38(5):222-6. PubMed ID: 8284922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru.
    Watts DM; Lavera V; Callahan J; Rossi C; Oberste MS; Roehrig JT; Cropp CB; Karabatsos N; Smith JF; Gubler DJ; Wooster MT; Nelson WM; Hayes CG
    Am J Trop Med Hyg; 1997 Jun; 56(6):661-7. PubMed ID: 9230800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of glucose metabolism in rhesus monkeys after Venezuelan equine encephalitis virus infection.
    Bowen GS; Rayfield EJ; Monath TP; Kemp GE
    J Med Virol; 1980; 6(3):227-34. PubMed ID: 7014785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus.
    Valero N; Nery A; Bonilla E; Espina LM; Chacin-Bonilla L; Añez F; Maldonado M; Meleán E
    Neurochem Res; 2009 Feb; 34(2):268-73. PubMed ID: 18594966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spread of Venezuelan equine encephalitis virus in mice olfactory tract.
    Ryzhikov AB; Ryabchikova EI; Sergeev AN; Tkacheva NV
    Arch Virol; 1995; 140(12):2243-54. PubMed ID: 8572944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.
    Turell MJ; Ludwig GV; Kondig J; Smith JF
    Am J Trop Med Hyg; 1999 Jun; 60(6):1041-4. PubMed ID: 10403340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of angiotensin II in experimental Venezuelan equine encephalitis in rats.
    Bermúdez J; Valero N; Mosquera J; Vargas R; Hernández-Fonseca JP; Quiroz Y; Godoy R
    Arch Virol; 2015 Oct; 160(10):2395-405. PubMed ID: 26156105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin decreases nitric oxide production and lipid peroxidation and increases interleukin-1 beta in the brain of mice infected by the Venezuelan equine encephalomyelitis virus.
    Valero N; MarinaEspina L; Bonilla E; Mosquera J
    J Pineal Res; 2007 Mar; 42(2):107-12. PubMed ID: 17286740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocytes as targets for Venezuelan equine encephalitis virus infection.
    Schoneboom BA; Fultz MJ; Miller TH; McKinney LC; Grieder FB
    J Neurovirol; 1999 Aug; 5(4):342-54. PubMed ID: 10463856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
    Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
    Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.